Trial record 7 of 756 for:
Fibrinolytic Therapy | Recruiting, Not yet recruiting, Active, not recruiting, Completed, Enrolling by invitation Studies | Industry
A Study Evaluating the Safety and Efficacy of Tirofiban in Combination With Alteplase in Acute Ischemic Stroke (RESET)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05188417 |
Recruitment Status :
Active, not recruiting
First Posted : January 12, 2022
Last Update Posted : February 23, 2023
|
Sponsor:
GrandPharma (China) Co., Ltd.
Information provided by (Responsible Party):
GrandPharma (China) Co., Ltd.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Estimated Primary Completion Date : | March 30, 2023 |
Estimated Study Completion Date : | June 30, 2023 |